Several countries have, in recent months, cracked down
on the manufacture, supply and sale of products containing
methylhexaneamine (MHA) as dietary supplements, leading to speculation
that the substance may no longer be available as an across-the-counter
nutritional aid.
Last month, the Medicines and
Healthcare products Regulatory Agency (MHRA) of the U. K., ruled that
products containing methylhexaneamine needed to be removed from the UK
market because of “potential risks to public safety.”
Stimulant
The
drug, also known by several other chemical names, including
dimethylamylamine (DMAA), is an ingredient of many dietary supplements
that are used by sportspersons. Other supplements have also been found
contaminated often with this drug which is categorised as a stimulant
and banned by the World Anti-Doping Agency (WADA).
It
has been claimed during the past few years that MHA was derived from
the geranium plant, especially its oil and root extract. Being a natural
substance, and as part of dietary supplements, it escaped regulations
applicable to drugs in several countries.
One of the
most popular products containing MHA, Jack3D, produced by USP Labs,
Dallas, Texas, has been ordered to be removed by retailers, among other
supplements, by the MHRA, UK. In a release dated August 28 last, the
MHRA stated that Jack3D was an “unlicensed medicinal product”.
The
UK decision followed a similar action by the Therapeutic Goods
Administration (TGA), Australia, early last month banning the use of
DMAA which is also considered as a ‘party drug’.
Toxic substance
“The
TGA urges people not to obtain, supply or use DMAA. DMAA is a toxic
substance with dangerous side effects. Buying such substances over the
internet is risky.”
The TGA statement said that on
August 2 last, the Western Australia State Coroner found that a mine
worker had died from taking DMAA, which he had bought over the internet.
The TGA ban includes personal use of DMAA, whether “bought over the
internet or not”.
The Food and Drug Administration
(FDA), USA, issued warning letters to 10 manufacturers of dietary
supplements including USP Labs, last April stating that they were
marketing the products without having submitted evidence of their safety
to the FDA.
The FDA said in a release that since
such manufacturers had not submitted evidence of safety, products
containing DMAA would be considered as “adulterated”. The FDA move
followed a decision of the US Department of Defence that temporarily
banned the sale of products containing DMAA within military facilities
following deaths of two soldiers suspected to be due to DMAA use.
Health
Canada had categorised DMAA as a medicinal product as far back as
August 2011, and stated that any product containing DMAA required
authorisation from Health Canada as a drug in order to be sold legally
in Canada.
Industry’s take
The MHA
supplements industry has repeatedly stated that the products are safe
and they actually contain natural ingredients. The claim that geranium
oil contained MHA, as reported in a single research by a group of
Chinese scientists in 1996, has since been challenged by a few other
studies notably by a group of Australian scientists in 2011.
Health
Canada stated last year that there was no credible scientific evidence
to show that DMAA had been “captured as an isolate of a plant”.
Without
verification by competent authorities, and mainly based on internet
searches, many so-called ‘experts’ in India had branded MHA as an
ingredient of geranium oil since it was brought into the Prohibited List
in January 2010. It was also suggested that massaging with geranium oil
or using lotions, soaps or face-packs containing the substance could
trigger a ‘positive’ test for MHA.
No regulation in India
There
is no regulation in India to oversee supplements distribution or sale. A
number of foreign products are available in the market and are often
sold near gyms, and at venues holding sports events. These arealso
available on the internet.
A spokesman for the Food
Safety Standards Authority of India (FSSAI) said on Tuesday that
regulations for supplements distribution in the country could soon be in
the offing.
No comments:
Post a Comment